NeurAxis, Inc. (NASDAQ:NRXS – Get Free Report) shares traded down 5.3% on Friday . The company traded as low as $2.50 and last traded at $2.50. 27,404 shares traded hands during mid-day trading, an increase of 138% from the average session volume of 11,518 shares. The stock had previously closed at $2.64.
NeurAxis Stock Performance
The stock has a market cap of $17.31 million, a price-to-earnings ratio of -1.35 and a beta of 4.15. The business’s 50 day moving average is $2.88 and its 200 day moving average is $2.96.
NeurAxis Company Profile
NeurAxis, Inc, a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome.
Read More
- Five stocks we like better than NeurAxis
- How to Use the MarketBeat Excel Dividend Calculator
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Retail Stocks Investing, Explained
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Are Penny Stocks a Good Fit for Your Portfolio?
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for NeurAxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeurAxis and related companies with MarketBeat.com's FREE daily email newsletter.
